Autolus Therapeutics plc
AUTL
$1.59
$0.117.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.30% | 132.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.30% | 132.94% | |||
| Cost of Revenue | 117.67% | -41.88% | |||
| Gross Profit | -599.82% | 85.86% | |||
| SG&A Expenses | 19.87% | 2.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.00% | 10.67% | |||
| Operating Income | -17.00% | 6.16% | |||
| Income Before Tax | -65.37% | 30.05% | |||
| Income Tax Expenses | 34.01% | -82.16% | |||
| Earnings from Continuing Operations | -65.11% | 31.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -65.11% | 31.70% | |||
| EBIT | -17.00% | 6.16% | |||
| EBITDA | -17.39% | 6.53% | |||
| EPS Basic | -65.17% | 31.71% | |||
| Normalized Basic EPS | -65.32% | 30.03% | |||
| EPS Diluted | -65.17% | 31.71% | |||
| Normalized Diluted EPS | -65.32% | 30.03% | |||
| Average Basic Shares Outstanding | 0.00% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||